Pfizer and BioNTech Seek FDA Nod For COVID Booster Shot For Children

On Monday, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced that they have submitted an Emergency Use Authorization EUA request to the FDA for a 10 -µg booster dose of its Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children ages 5 through 11 years of age. Nice!

Read more about it

Photo Credit: Artur Aldyrkhanov